{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:43:50Z","timestamp":1794656630662,"version":"4.9.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>Sepsis is a leading cause of mortality in low- and middle-income countries. This study identifies computable pediatric sepsis phenotypes (PedSep A, B, C, and D) previously derived in a U.S. cohort in a new independent Argentine cohort to assess plausibility for its use in personalized clinical trials in Pan-American children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN:<\/jats:title>\n                    <jats:p>This retrospective cohort study uses data from the Argentinian ESSPED2 (Estudio Sepsis y Shock S\u00e9ptico Pedi\u00e1trico 2) Registry and the Phenotyping Pediatric Sepsis-Induced Multiple Organ Failure U.S. study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING:<\/jats:title>\n                    <jats:p>The Argentine cohort was recruited from 51 PICUs between September 15 and December 15, 2021. The U.S. cohort involved nine PICUs between 2015 and 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS:<\/jats:title>\n                    <jats:p>The Argentine cohort included 99 sepsis patients aged 1 month to 18 years, and the U.S. cohort included 404 sepsis patients, aged 44 weeks of gestation to 18 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTIONS:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n                    <jats:p>\n                      Membership in the PedSep A, B, C, or D phenotype was identified using a computable tool (https:\/\/pedsepsis.pitt.edu) requiring 25 bedside variables at 24 hours. Phenotype prevalence and mortality were compared between Argentine and U.S. cohorts. Heterogeneity of treatment responses and power analyses were performed in the combined cohort. Mortality rates were 20 of 99 (20.2%) in Argentina and 45 of 404 (11.14%) in the United States (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.025). Mortality was highest in PedSep D computable phenotype, with 9 of 28 (32.14%) in Argentina and 19 of 56 (33.93%) in the United States (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 1.0). Heterogeneity of treatment response to anti-inflammatory therapies was observed in PedSep D compared with PedSep A, B, and C children (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.05). Sample size calculations support the requirement for 55 PedSep D patients per arm to demonstrate reduction in mortality with dexamethasone or methylprednisolone with gammaglobulin compared with placebo.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>The PedSep computable tool can identify PedSep D children for enrollment in combined Argentina\u2013U.S. randomized controlled trials evaluating effectiveness of anti-inflammatory treatment in hyperinflammatory sepsis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pcc.0000000000004023","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:00:10Z","timestamp":1786975210000},"page":"1183-1194","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of a Computable Pediatric Sepsis Phenotype Tool in Argentinian and U.S. Cohorts"],"prefix":"10.1097","volume":"27","author":[{"given":"Rebecca I.","family":"Caldino Bohn","sequence":"first","affiliation":[{"name":"Department of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eugenia","family":"Galvan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital de Pediatr\u00eda \u201cJ.P.Garrahan,\u201d Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa S.","family":"Lanziotti","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Clinical Research and Technological Innovation Division, Pediatric Hospital (IPPMG), Federal University of Rio de Janeiro, Rio de Janeiro, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate F.","family":"Kernan","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine and Pediatrics, School of Medicine, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Viqueira","family":"Guzm\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital de Pediatr\u00eda \u201cJ.P.Garrahan,\u201d Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Vassallo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital de Pediatr\u00eda \u201cJ.P.Garrahan,\u201d Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Carcillo","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine and Pediatrics, School of Medicine, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Landry","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital de Pediatr\u00eda \u201cJ.P.Garrahan,\u201d Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun\u2011Jung","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvina","family":"Ruvinsky","sequence":"additional","affiliation":[{"name":"Head of Research Department, Hospital de Pediatr\u00eda \u201cJ.P.Garrahan,\u201d Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Santos","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital de Pediatr\u00eda \u201cJ.P.Garrahan,\u201d Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Jabornisky","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Juan Pablo II, Corrientes, Argentina, Corrientes, Argentina."},{"name":"Department of Pediatrics, Universidad Nacional del Nordeste, Corrientes, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Members of Argentinian ESSPED2 (Estudio Sepsis y Shock S\u00e9ptico Pedi\u00e1trico 2) Registry and the Phenotyping Pediatric Sepsis-Induced Multiple Organ Failure U.S. study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"R1-20261008","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S2213-2600(18)30063-8","article-title":"The global burden of paediatric and neonatal sepsis: A systematic review.","volume":"6","author":"Fleischmann-Struzek","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R2-20261008","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of Disease Study.","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"R3-20261008","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2352-4642(21)00286-8","article-title":"The epidemiology of sepsis in paediatric intensive care units in Brazil (the Sepsis PREvalence Assessment Database in Pediatric population, SPREAD PED): An observational study.","volume":"5","author":"de Souza","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"R4-20261008","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R5-20261008","doi-asserted-by":"crossref","first-page":"100817","DOI":"10.1016\/j.xcrm.2022.100817","article-title":"Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial.","volume":"3","author":"Leventogiannis","year":"2022","journal-title":"Cell Rep Med"},{"key":"R6-20261008","doi-asserted-by":"crossref","first-page":"100823","DOI":"10.1016\/j.xcrm.2022.100823","article-title":"Identifying inflammatory phenotypes to target mechanism-specific treatments in sepsis.","volume":"3","author":"Gomez","year":"2022","journal-title":"Cell Rep Med"},{"key":"R7-20261008","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5935\/0103-507X.20220069-en","article-title":"Subphenotyping of critical illness: Where protocolized and personalized intensive care medicine meet.","volume":"34","author":"Ramos","year":"2022","journal-title":"Rev Bras Ter Intensiva"},{"key":"R8-20261008","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1097\/CCM.0000000000001852","article-title":"Pediatric sepsis biomarker risk model-II: Redefining the pediatric sepsis biomarker risk model with septic shock phenotype.","volume":"44","author":"Wong","year":"2016","journal-title":"Crit Care Med"},{"key":"R9-20261008","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/PCC.0000000000002422","article-title":"Pediatric sepsis: Subphenotypes to enrich clinical trial entry criteria.","volume":"21","author":"Lanziotti","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R10-20261008","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s13054-022-04265-w","article-title":"Commentary: \u2018Critical illness subclasses: All roads lead to Rome\u2019.","volume":"26","author":"Atreya","year":"2022","journal-title":"Crit Care"},{"key":"R11-20261008","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis.","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"R12-20261008","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/PCC.0000000000002105","article-title":"A multicenter network assessment of three inflammation phenotypes in pediatric sepsis-induced multiple organ failure.","volume":"20","author":"Carcillo","year":"2019","journal-title":"Pediatr Crit Care Med"},{"key":"R13-20261008","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13054-022-03977-3","article-title":"Machine learning derivation of four computable 24-h pediatric sepsis phenotypes to facilitate enrollment in early personalized anti-inflammatory clinical trials.","volume":"26","author":"Qin","year":"2022","journal-title":"Crit Care"},{"key":"R14-20261008","first-page":"e2025","article-title":"Second epidemiological study of pediatric sepsis and septic shock in Argentina.","volume":"123","author":"Galvan","year":"2025","journal-title":"Arch Argent Pediatr"},{"key":"R15-20261008","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics.","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R16-20261008","doi-asserted-by":"crossref","first-page":"e172352","DOI":"10.1001\/jamapediatrics.2017.2352","article-title":"Adaptation and validation of a pediatric sequential organ failure assessment score and evaluation of the sepsis-3 definitions in critically ill children.","volume":"171","author":"Matics","year":"2017","journal-title":"JAMA Pediatr"},{"key":"R17-20261008","first-page":"1","article-title":"mice: Multivariate imputation by chained equations in R.","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"R18-20261008","doi-asserted-by":"crossref","first-page":"861","DOI":"10.21105\/joss.00861","article-title":"UMAP: Uniform manifold approximation and projection.","volume":"3","author":"McInnes","year":"2018","journal-title":"JOSS"},{"key":"R19-20261008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building predictive models in R using the caret package.","volume":"28","author":"Kuhn","year":"2008","journal-title":"J Stat Softw"},{"key":"R20-20261008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent.","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"R21-20261008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v106.i01","article-title":"Elastic net regularization paths for all generalized linear models.","volume":"106","author":"Tay","year":"2023","journal-title":"J Stat Softw"},{"key":"R23-20261008","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences.","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"R25-20261008","first-page":"66","article-title":"Pediatric intensive care: Collaborative work on population characteristics and risk groups.","volume":"95","author":"Saporiti","year":"1997","journal-title":"Arch Argent Pediatr"},{"key":"R26-20261008","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/ard-2023-224123","article-title":"The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS).","volume":"82","author":"Shakoory","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R27-20261008","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/art.42636","article-title":"The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS).","volume":"75","author":"Shakoory","year":"2023","journal-title":"Arthritis Rheumatol"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PCC.0000000000004023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:00:45Z","timestamp":1791468045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PCC.0000000000004023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000004023","relation":{},"ISSN":["1529-7535","1947-3893"],"issn-type":[{"value":"1529-7535","type":"print"},{"value":"1947-3893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]}}}